NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling

Go back to NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
NEOGENOMICS (NASDAQ: NEO) Delayed: 15.16 +0.19 (1.27%)
Previous Close $14.97    52 Week High $9.54 
Open $15.00    52 Week Low $5.49 
Day High $15.56    P/E 379.00 
Day Low $15.00    EPS $0.04 
Volume 2,179,064